NCT04089566 Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Status COMPLETED Phase PHASE3
NCT04079101 Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants Status COMPLETED Phase PHASE1
NCT04079088 Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS) Status WITHDRAWN Phase PHASE2
NCT04068532 A Study to Explore Pharmacodynamic Effects of BIIB104 on Brain Circuitry in Healthy Participants Status COMPLETED Phase PHASE1
NCT04056689 Study to Evaluate DNL151 in Subjects With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT04048577 A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab Status UNKNOWN Phase PHASE4
NCT04008186 A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone Status COMPLETED Phase PHASE1
NCT04007367 A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder Status TERMINATED Phase PHASE3
NCT03958877 A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03945279 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT03943056 A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT03926637 Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis Status TERMINATED Phase N/A
NCT03918447 A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON Status TERMINATED Phase PHASE3
NCT03902002 A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT03887455 A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03870763 Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants Status TERMINATED Phase PHASE3
NCT03864614 A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3